Thia Medica As
Records under this name other than patents Thia Medica As holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Thia Medica As
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,659,242 | Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities Formerly held In force · USPTO record | In force | USPTO record | |
| US 6,441,036 | Fatty analogues for the treatment of obesity, hypertension and fatty liver Formerly held Term ended Term ended Jan 27, 2021 · USPTO record | Term ended | Term ended Jan 27, 2021 | USPTO record |
| US 6,365,628 | Fatty analogues for the treatment of diabetes Formerly held Term ended Term ended Jan 8, 2021 · USPTO record | Term ended | Term ended Jan 8, 2021 | USPTO record |
| US 6,417,232 | Fatty acid analogues for the treatment of primary and secondary restenosis Term ended Term ended Jan 8, 2021 · USPTO record | Term ended | Term ended Jan 8, 2021 | USPTO record |
| US 8,088,825 | Fatty acid analogues for the treatment of inflammatory and autoimmune disorders Formerly held Lapsed on the fee record Ended Jan 3, 2020 · USPTO record | Lapsed on the fee record | Ended Jan 3, 2020 | USPTO record |
| US 7,902,399 | Fatty acids analogous Formerly held Lapsed on the fee record Ended Mar 8, 2019 · USPTO record | Lapsed on the fee record | Ended Mar 8, 2019 | USPTO record |
| US 7,026,356 | Fatty acid analogues for the treatment of diseases caused by the pathological proliferation of smooth muscle cells Lapsed on the fee record Ended Apr 11, 2018 · USPTO record | Lapsed on the fee record | Ended Apr 11, 2018 | USPTO record |
| US 7,378,443 | Fatty acid analogues for the treatment of cancer Lapsed on the fee record Ended May 27, 2016 · USPTO record | Lapsed on the fee record | Ended May 27, 2016 | USPTO record |
| US 7,230,029 | Fatty acid analogues for the treatment of proliferative skin disorders Lapsed on the fee record Ended Jun 12, 2011 · USPTO record | Lapsed on the fee record | Ended Jun 12, 2011 | USPTO record |